QURE vs SNDX: stock comparison and AI forecast
Uniqure N.V. (QURE) and Syndax Pharmaceuticals Inc (SNDX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
QURE Uniqure N.V.
- Price
- $21.01 -7.9% · 6M
- Market Cap
- $1.47B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SNDX Syndax Pharmaceuticals Inc
- Price
- $10.45 -49.4% · 6M
- Market Cap
- $837M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- QURE is 1.8 times larger than SNDX by market capitalization ($1.47B against $837M).
- Over the last six months QURE returned -7.9% and SNDX -49.4%.
- SNDX turns -60.3% of its revenue into net income, against -1154.8% for QURE.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | QURE | SNDX |
|---|---|---|
| Market Cap | $1.47B | $837M |
| P/B Ratio | 4.99x | – |
| EPS | $-4.36 | $-3.35 |
| Book Value/Share | $4.21 | – |
| Revenue/Share | $0.29 | $3.89 |
| FCF/Share | $-2.76 | – |
Profitability & Margins
| Metric | QURE | SNDX |
|---|---|---|
| ROE | -79.0% | – |
| ROA | -24.8% | -30.2% |
| ROIC | -22.9% | -31.2% |
| Gross Margin | 89.6% | – |
| Operating Margin | -1001.7% | -51.4% |
| Net Margin | -1154.8% | -60.3% |
| EBT Margin | -1159.4% | -51.4% |
| Tax Rate | 0.4% | -0.2% |
Financial Health
| Metric | QURE | SNDX |
|---|---|---|
| Current Ratio | 11.52x | 4.69x |
| Quick Ratio | – | 4.37x |
| D/E Ratio | 2.19x | – |
| Financial Leverage | 3.19x | – |
| Interest Coverage | -7.1x | 963.6x |
| Working Capital | $632M | $446M |
Cash Flow
| Metric | QURE | SNDX |
|---|---|---|
| Operating Cash Flow | -$192M | -$177M |
| Free Cash Flow | -$193M | – |
| Capital Spending | -$740K | – |
| FCF/Sales | -956.8% | – |
| CapEx/Sales | 3.7% | – |
Operational Efficiency
| Metric | QURE | SNDX |
|---|---|---|
| Asset Turnover | 0.02x | 0.50x |
| Receivables Turnover | 4.2x | – |
| Fixed Assets Turnover | 2.0x | 1686.6x |
| Days Sales Outstanding | 87 days | – |
| Payables Period | 1817 days | – |
Income Statement
| Metric | QURE | SNDX |
|---|---|---|
| Total Revenue | $20M | $347M |
| Operating Income | -$202M | -$179M |
| Net Income | -$233M | -$209M |
| R&D Expense | $133M | $273M |
| SG&A Expense | $83M | – |
| Cost of Goods Sold | $1M | – |
Dividend & Shareholder Information
| Metric | QURE | SNDX |
|---|---|---|
| Shares Outstanding | 70M | 89M |
QURE vs SNDX: stock comparison and AI forecast
Which is bigger, QURE or SNDX?
QURE is 1.8 times larger than SNDX by market capitalization ($1.47B against $837M).
Which stock performed better over the last six months, QURE or SNDX?
Over the last six months QURE returned -7.9% and SNDX -49.4%.
Which one does Intratio's AI model rank higher, QURE or SNDX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.